Fredun Pharmaceuticals Ltd — Important, 13-01-2026: Company Update

Fredun Pharmaceuticals announced the successful processing of share dematerialization for the quarter ending December 2025. Its Registrar and Share Transfer Agent confirmed that all physical shares received from investors were converted to electronic form and listed on stock exchanges, facilitating easier trading. The company ensured that all corresponding physical certificates were duly cancelled, and depository records updated in the register of members. This confirms efficient and compliant management of share transfers. A total of 3300 shares were dematerialized during this period.